Institutional Ownership Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT). We have compiled data on the 197 institutions that hold shares in the stock, with a total of 129 Million shares, which have been reported (via 13F filing form) to have a value of $1.82 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jennison Associates LLC
|
Nov 08, 2024 Q3 2024 |
11,663,497
shares
|
$175 Million
0.07% of portfolio
|
Q3 2024
Added 0.79%
|
|
|
Rubric Capital Management LP
New York, NY |
Nov 13, 2024 Q3 2024 |
10,966,672
shares
|
$164 Million
2.84% of portfolio
|
Q3 2024
Added 11.71%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
10,721,511
shares
|
$161 Million
3.92% of portfolio
|
Q3 2024
Added 7.17%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
8,785,284
shares
|
$132 Million
4.4% of portfolio
|
Q1 2024
Added 0.24%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,618
shares
|
$129 Million
0.0% of portfolio
|
Q2 2024
Added 29.49%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
6,962,635
shares
|
$104 Million
0.0% of portfolio
|
Q3 2024
Added 13.32%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
6,884,372
shares
|
$103 Million
0.39% of portfolio
|
Q3 2024
Added 0.08%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
5,641,631
shares
|
$84.6 Million
0.0% of portfolio
|
Q3 2024
Added 9.87%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 27, 2024 Q3 2024 |
4,250,418
shares
|
$63.7 Million
0.01% of portfolio
|
Q3 2024
Reduced 4.23%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
3,781,195
shares
|
$56.7 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.82%
|
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
3,553,838
shares
|
$53.3 Million
0.42% of portfolio
|
Q3 2024
Reduced 1.73%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
3,031,073
shares
|
$45.4 Million
0.01% of portfolio
|
Q3 2024
Added 3.36%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,470,138
shares
|
$37 Million
0.0% of portfolio
|
Q3 2024
Added 2.02%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
2,416,812
shares
|
$36.2 Million
0.04% of portfolio
|
Q3 2024
Added 13.27%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,325,000
shares
|
$34.9 Million
1.51% of portfolio
|
Q3 2024
Reduced 7.92%
|
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
2,120,508
shares
|
$31.8 Million
15.54% of portfolio
|
Q3 2024
Added 3.89%
|
|
|
Stem Point Capital LP
New York, NY |
Nov 13, 2024 Q3 2024 |
1,778,318
shares
|
$26.7 Million
4.95% of portfolio
|
Q3 2024
Added 84.21%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
1,745,024
shares
|
$26.2 Million
0.02% of portfolio
|
Q3 2024
Added 73.22%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 07, 2024 Q3 2024 |
1,593,630
shares
|
$23.9 Million
0.13% of portfolio
|
Q3 2024
Reduced 4.46%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,589,882
shares
|
$23.8 Million
0.0% of portfolio
|
Q3 2024
Added 96.93%
|
|
|
J. Goldman & CO LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,492,217
shares
|
$22.4 Million
0.43% of portfolio
|
Q3 2024
Added 13.78%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
1,464,311
shares
|
$22 Million
0.01% of portfolio
|
Q3 2024
Added 18.89%
|
|
|
Candriam S.C.A.
|
Nov 13, 2024 Q3 2024 |
1,426,496
shares
|
$21.4 Million
0.08% of portfolio
|
Q3 2024
Added 9.1%
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,358,500
shares
|
$20.4 Million
0.33% of portfolio
|
Q3 2024
Reduced 12.83%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,327,029
shares
|
$19.9 Million
0.02% of portfolio
|
Q2 2023
Reduced 19.87%
|